# First personalised cancer vaccine cuts risk of disease returning in major trial

> **Newsylist Open Intelligence Dossier** · First detected: 2026-10-23 14:29 UTC · Category: Business · Sources: 7 · Current Velocity: 5.95

## Intelligence Brief
"First personalised cancer vaccine cuts risk of disease returning in major trial" developed substantial multi-source reporting across the Business sector, tracked across 6 distinct newsrooms by Newsylist.


Key reporting was led by CNBC, Yahoo, Yahoo Finance and Investor's Business Daily. Coverage velocity and cross-outlet momentum were measured using Newsylist open coverage telemetry.


Synthesized from multi-source international reporting and live coverage telemetry under Newsylist open intelligence methodology.

## Verified Facts & Key Claims
### What drove coverage for First personalised cancer vaccine cuts risk of disease returning in major t?
Coverage spiked when 6 independent newsrooms published 8 verified reports during this coverage cycle.

### How did Newsylist track this trend?
Newsylist monitored article arrival rates, source diversity, and cross-outlet validation in real time.

## Multi-Source Evidence Table
| Source Outlet | Headline | Published (UTC) | Verification URL |
|---|---|---|---|
| NBC News | Personalized mRNA vaccine for melanoma cut risk of cancer’s return in late-stage trial | 2026-10-23 07:49 | [Source Link](https://news.google.com/rss/articles/CBMiugFBVV95cUxOZGd4TmxtWGtzQTdiUlllRjVaWUFlNmpESnN4bW80RXJudFhlb1dMbFlmTTNSVVBXWlcwS0xqaDlIcGtwYThmOGx0azItWlRIQ3gzU2ZtOE02eUNKQTJKR25YUTVMUE94NW14RFI5WGQtbEpOaU5BYzl4ZENFRzZrX0JrTGZQQUpacl9XelFUWDIxNU9GbmFGWnhhRkRjTHZSNUFON3lEY2U3YXhoXzlQRExfdl9jYk81bWc?oc=5) |
| CNBC | Doctors call Moderna, Merck's cancer vaccine data a major advancement | 2026-10-23 07:49 | [Source Link](https://news.google.com/rss/articles/CBMiekFVX3lxTFBic1BjZTVUN190b0lyOGkyTmx1UDlvaGpiY3psNXlwOEFpQXIxZTZxOU1FZWQzRlVjTS04T0c0ZXJ2Wm9rVWk4OTJqT25kcXpaS2xpMTlnWjcwQWlMSzZHWGxKTkJaY0NjNGRuYWExSGw3dng1RjQwV0pn0gF_QVVfeXFMTUpnRDVLVmItbUdwM01ncEZJWWZOMzRqMTJJY1R6RTBIcHllTnQ5OEV3eHhiRmk1UTg5Sk9jNFgyUk95RTVSSk9PclU1WU5ORG54RnV6NVM4SmZiRnEtZ1NDaGhwUWZNdHlRcXZ0Tk5KOGYyOUpYUk1COG1zOUExWQ?oc=5) |
| Yahoo | Cancer vaccine reduces melanoma from returning by 42%, data shows | 2026-10-23 07:49 | [Source Link](https://news.google.com/rss/articles/CBMiogFBVV95cUxNTm0zanNmOGVfMkhtOTdOeEhvemhYVXU5dFRjWEYtZkhZX3hxS0RsU3lVaktZSzNIWEtnNVN6bVFhSHhOcS1QSmNBVU9lS0dfQk9xU3M4d1hTamF5ZzRJV0ZmN0w2bVlnWGk5eV9xUldjbm1wY2dkM0lGalRaOTUzQS15TGdCLVV0SGVsQ2lvMm5RbGtRd29hY3VycGNPckZfeXc?oc=5) |
| Yahoo Finance | Moderna trims losses as investors digest melanoma vaccine trial data | 2026-10-23 07:49 | [Source Link](https://news.google.com/rss/articles/CBMizAFBVV95cUxPR2FLaVVoRTVSeVNnX1ZwY21VU1hBWTF0eTU1UTJxejUxNEhxRGw1MkNzcU16VzVpZk5wVjc0TmhxY21taHMwMlVKbGhJUmoxekwwN3VTM29BSW0zR2NzMS1mLU01Q2V5cEphR09FYlFnMl83eWhYMnFIc0hRN1c3cm9rV25jM0RKNXNSRUlKbWxZR1RQRU03Mldxc2Y0MWJ0YVlTSzZyMTUtaVNEQ0xmNzQycEF6UnJNeFE2bVoxbEJfQ1dLbUF0eHB2MW0?oc=5) |
| Investor's Business Daily | Will These Nuances Undo Merck And Moderna's Cancer Vaccine? | 2026-10-23 07:49 | [Source Link](https://news.google.com/rss/articles/CBMiiwFBVV95cUxPTS1mNXBmbHBQeGdTbHg2b1NFN1FGVFVQTXNLbGpGOUluVjNUN3h1NDZvXzR4dWQzckwzMjA5Mk5aSlk3RTh4Ymp4OE5JczNIcmJFUlJlRlNEcXFVMWZBeFJjai05Qmd5ZTdjM2Jxa2E2Y1VVb2JXY1dEd0FvN2VXb0t6OV9wcUhreUhr?oc=5) |
| Yahoo Finance | Moderna’s Stock Just Stumbled. Is It a Buy on the Dip? | 2026-10-23 07:49 | [Source Link](https://news.google.com/rss/articles/CBMinAFBVV95cUxNUmV4cUpZNDFLeGNNU0VFVThaWnBsUVJjRmx0aGRsTk9fTmdZQmhDMU5sQ1p0QndrejF0ZFZvVVMzTVFScDRGSEhTQWVCamdXT2ktRWdTMnBaNm4yZGZDZ1N5T1Rya0lBMEdwcVRpOTRNZlR3M2U3cS1VeUR1VHh1MTBpaWF2NFB2Sk16MDZ0bXVCRF9XaHVRdFFtTEY?oc=5) |
| Yahoo | A novel mRNA cancer vaccine helps reduce the chances of melanoma patients' tumors returning | 2026-10-23 07:49 | [Source Link](https://news.google.com/rss/articles/CBMilAFBVV95cUxOSmlFNjRteHBKUkNkT3JISnlPa3JLcmVsY0hOWHhDaS1oZUxjSEplR0J3UjA4ZWFYTTRMMWVmWUU4X3RwUFY0bl9UbVNjX3Jodmd0U2VVbEpPYUNRellkbUNWLUpPVE5aQlo3eGw0ZS15S0RGNWJNWkxYRENsclNKS0kzR2FSU1B6cjhJNzlrdEZvdjVJ?oc=5) |
| STAT | Pharmalittle: We're reading about a cancer vaccine, an experimental pancreatic cancer drug, and more | 2026-10-23 07:49 | [Source Link](https://news.google.com/rss/articles/CBMitwFBVV95cUxPak9FRjJmMl9DQ0Q2T0E3cUdldFBXX2lTdnVESDRRTnEwcDRSeUk5aXJlQ2NabTY1M0JNYmVudEVnR0Fva0tIbDFtVFR0RXlTUEpiYURiSFpCbV9aNFpQSGUzU2JRS0JyWU5USUk3Q1VKMFhDNEczVk5kczhnTGlqSmE1bG1nT1M3WHFlQkRaNGZlR2NWTGluZVpZdW9Ka0VGSk5TbkwyeWg0dHRCYXJVamNBUDBWaDQ?oc=5) |
| The New York Times | First-of-Its-Kind Vaccine Ushers in New Hope for Cancer Patients | 2026-10-23 07:49 | [Source Link](https://news.google.com/rss/articles/CBMif0FVX3lxTE1jczI3bThhd0tzY1p0ZzlZQ2ViR2Q3V0dFaVNSa0hYQWRtNG8xLXItWW1tZFBZN3Q1WlRoSXhuVjVsMVlmUXVpLWM2c2hJVUlhQVRQREE1UlR1VnU0WWJZa3ExVDk2dTl4WnUwVEVaSVVHYzNhMTVqUFJlby1EMjA?oc=5) |

---
*Canonical Source: https://www.newsylist.com/trend/2026-10-23/first-personalised-cancer-vaccine-cuts-risk-of-disease-returning-in-major-trial*
*Synthesized by Newsylist Open Intelligence Engine under E-E-A-T journalistic standards.*